Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Aging Frailty
Authors not listed
The Foundation for Orthopaedics and Regenerative Medicine · 2022
Abstract
This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Aging Frailty
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-15 MST
Cite this
APA
Anonymous. (2022). Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Aging Frailty. <em>The Foundation for Orthopaedics and Regenerative Medicine</em>. https://clinicaltrials.gov/study/NCT05018767
Vancouver
Anonymous. Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Aging Frailty. The Foundation for Orthopaedics and Regenerative Medicine. 2022.
BibTeX
@misc{anon2022Safety,
title = {Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Aging Frailty},
author = {Anonymous},
journal = {The Foundation for Orthopaedics and Regenerative Medicine},
year = {2022},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Longeveron Inc. 2014
Open access · US-GOV
A Phase I/II, Randomized, Blinded and Placebo-controlled Trial to Evaluate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion in Patients With Aging Frailty
Mechanisms of Ageing and Development 2019
Citation only
Attenuation of frailty in older adults with mesenchymal stem cells
Shanghai East Hospital 2020
Open access · US-GOV
A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Study of Umbilical Cord Mesenchymal Stem Cells Infusion for Aging Frailty
Vinmec Research Institute of Stem Cell and Gene Technology 2021
Open access · US-GOV
Clinical Study of Mesenchymal Stem/Stromal Cell Therapy in Frailty: a Proposed Experimental Design for Therapeutic and Mechanism Investigation
Meribank Biotech Co., Ltd. 2024
Open access · US-GOV
A Two-part, Phase I/II, Randomized, Single-blind Study to Evaluate the Efficacy and Safety of UMC119-06-05 in Older Adults With Pre-frailty & Frailty
VA Office of Research and Development 2023
Open access · US-GOV